Ian A Wilson of ImaginAb delivers the presentation ‘The Value of In Vivo Imaging on the Clinical Development of IO Drugs’ at Oxford Global’s discussion group.

Oxford Global’s Immuno Week showcased new ways of reprogramming the immune system to treat malignancy with TCR-T.

An interview with Rajika Perera, Chief Executive Officer, Poseidon Laboratory

Improving preclinical modelling to translate drugs to the clinic is one of the key priorities in immunotherapy and immuno-oncology today. We sat down with senior representatives from GemPharmatech and MiNA Therapeutics to find out how best to develop the next generation of preclinical modelling.

Video Interview | Pelin Candarliglou, Senior Investigator, GlaxoSmithKline

Presented by Néstor Vázquez Bernat, PHD – Application Specialist at ENPICOM

Bryan Glaser, Vice President, Business Development, Invenra Inc.

Loui Madakamutil, Senior Vice President, Head of Discovery and Preclinical Development, Nektar Therapeutics

Darrell Borger, Immuno-Oncology Laboratory Director, Translational Research/Biomarker Laboratory, Massachusetts General Hospital Cancer Center

Geert Mudde, CSO and Founder, OncoQR ML GmbH and TYG oncology Ltd